340 related articles for article (PubMed ID: 16987826)
1. Immunological basis of systemic sclerosis.
Zuber JP; Spertini F
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii23-5. PubMed ID: 16987826
[TBL] [Abstract][Full Text] [Related]
2. New developments in the pathogenesis of systemic sclerosis.
Sakkas LI
Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
[TBL] [Abstract][Full Text] [Related]
3. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
Hasegawa M; Fujimoto M; Takehara K; Sato S
J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
[TBL] [Abstract][Full Text] [Related]
5. [Immunopathological disturbances in systemic sclerosis].
Gindzieńska-Sieśkiewicz E; Klimiuk PA; Kowal-Bielecka O; Sierakowski S
Pol Merkur Lekarski; 2005 Dec; 19(114):800-3. PubMed ID: 16521427
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 1: pathogenesis].
Zuber JP; Chizzolini C; Leimgruber A; Bart PA; Spertini F
Rev Med Suisse; 2006 Apr; 2(62):1052-7. PubMed ID: 16711150
[TBL] [Abstract][Full Text] [Related]
7. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
Hasegawa M
J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
[TBL] [Abstract][Full Text] [Related]
8. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
9. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of systemic scleroderma: immunological aspects].
Mouthon L; García De La Peña-Lefebvre P; Chanseaud Y; Tamby MC; Boissier MC; Guillevin L
Ann Med Interne (Paris); 2002 May; 153(3):167-78. PubMed ID: 12218899
[TBL] [Abstract][Full Text] [Related]
11. [Physiopathology of scleroderma].
Fleischmajer R; Perlish JS; Maquart FX; Kalis B
Ann Dermatol Venereol; 1993; 120(2):157-66. PubMed ID: 8363310
[TBL] [Abstract][Full Text] [Related]
12. Update on pathophysiology of scleroderma with special reference to immunoinflammatory events.
Chizzolini C
Ann Med; 2007; 39(1):42-53. PubMed ID: 17364450
[TBL] [Abstract][Full Text] [Related]
13. The immunobiology of systemic sclerosis.
Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
[TBL] [Abstract][Full Text] [Related]
14. B cells in systemic sclerosis: a possible target for therapy.
Bosello S; De Luca G; Tolusso B; Lama G; Angelucci C; Sica G; Ferraccioli G
Autoimmun Rev; 2011 Aug; 10(10):624-30. PubMed ID: 21545850
[TBL] [Abstract][Full Text] [Related]
15. Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.
Gabrielli A; Svegliati S; Moroncini G; Luchetti M; Tonnini C; Avvedimento EV
Autoimmun Rev; 2007 Dec; 7(2):121-6. PubMed ID: 18035321
[TBL] [Abstract][Full Text] [Related]
16. Novel insights on the role of the innate immune system in systemic sclerosis.
York MR
Expert Rev Clin Immunol; 2011 Jul; 7(4):481-9. PubMed ID: 21790291
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis.
Sakkas LI; Chikanza IC; Platsoucas CD
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):679-85. PubMed ID: 17133253
[TBL] [Abstract][Full Text] [Related]
18. T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis.
Chizzolini C
Curr Opin Rheumatol; 2008 Nov; 20(6):707-12. PubMed ID: 18946333
[TBL] [Abstract][Full Text] [Related]
19. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
[TBL] [Abstract][Full Text] [Related]
20. Future targets in the management of systemic sclerosis.
Tyndall A; Matucci-Cerinic M; Müller-Ladner U
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii49-53. PubMed ID: 19487225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
